| [1] |
LIN Ziyi, JIANG Yanji, LIN Qiuling, WEI Xiaoxia, ZHOU Zihan, MA Yingying, LIN Biaoyang, YU Hongping, LIANG Xiumei.
Auxiliary diagnostic value of serum chitinase-3-like protein 1 levels in hepatitis B virus-related hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 582-589.
|
| [2] |
CHEN Mengmeng, CHEN Nan, XUE Junjie, FENG Lei.
Research progress on lactylation in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 640-646.
|
| [3] |
SU Jiayong, LIN Leipo, HUANG Zhihao, LI Jianrong, PAN Lixin, MA Liang, LI Lequn, MA Yili, ZHONG Jianhong.
Advancements in the study of tertiary lymphoid structures within solid tumors: A case analysis of hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 273-280.
|
| [4] |
LI Wenyang, SU Jiayong, LIU Shaoping, LIU Zhen, PENG Ning, LUO Min, FAN Yuan, LIN Leipo, MA Liang, LI Lequn, ZHONG Jianhong.
Efficacy of transcatheter arterial chemoembolization following radical resection in cases of intermediate to advanced hepatocellular carcinoma with microvascular invasion: A multicenter cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 281-288.
|
| [5] |
XU Shaowei, TANG Zhihong, WEI Meng, LIU Danxi, YUAN Du, PANG Qingqing, BAI Tao, CHEN Jie, WANG Xiaobo, LI Lequn, WU Feixiang.
Development and validation of a nomogram model for predicting pathological complete response following conversion therapy for hepatocellular carcinoma based on biological markers and imaging features
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 289-296.
|
| [6] |
NIE Liyun, NONG Qingqing, LI Jiangheng, GUAN Bin, HUANG Yuying, CHEN Yuyun.
Role of GCLC promoter methylation on microcystin?LR?induced hepatocyte malignant transformation and the interventional effects of 5?aza?2′?deoxycytidine
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 297-304.
|
| [7] |
LYU Ruibo, AN Sanchun, LI Yunxi, ZHANG Chaojun, QIU Jie, CHEN Xiaomei, LUO Yunbo, DENG Wei, HUANG Tianren.
Screening and follow-up results of the early diagnosis and treatment program for liver cancer: a data analysis based on Fusui County, Guangxi, 2011—2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 139-144.
|
| [8] |
LIANG Xiumei, CHEN Weiyi, ZHOU Zihan, MA Liang, WU Yun, LU Xiangning, XIANG Bangde, YU Hongping, LYU Hanbin.
Analysis of survival characteristics in liver cancer inpatients: a 10-year follow-up cohort from a cancer hospital in Guangxi (2010—2020)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 145-149.
|
| [9] |
SUN Jiamin , ZHANG Shiyi, LIAO Xiwen, ZHONG Jianhong, WANG Qiuyan , TAO Yuting.
Mechanism and clinical significance of collagen crosslinking-mediated extracellular matrix remodeling in
hepatocellular carcinoma dedifferentiation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 164-171.
|
| [10] |
LI Yongfeng, WAN Fengjie, WEN Sha, YANG Lichao, OU Meizhen, LIAO Zhouxiang, WU .
FAM50A gene knockdown suppresses malignant biological behaviors of colorectal cancer cells via the Caspase-3/PARP-mediated apoptotic signaling
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 180-187.
|
| [11] |
ZHANG Shiyi, SUN Jiamin, ZHONG Jianhong, WANG Qiuyan, TAO Yuting.
Clinical significance of YAP signaling activation in extracellular matrix remodeling in hepatocellular carcinoma and its molecular mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 30-39.
|
| [12] |
LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei.
Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
|
| [13] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
| [14] |
WANG Huimin, ZHAO Dongming, LI Xianfeng.
Research progress on multifunctional nano-drug delivery system in the treatment of liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 128-132.
|
| [15] |
LIN Leipo, HUANG Zhihao, XIANG Bangde, MA Liang, LI Lequn, ZHONG Jianhong .
Interpretation of 2024 ACG Clinical Guideline: Focal Liver Lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 656-662.
|
